Motus gi and nyu langone health partner to improve its inpatient colonoscopy management

Fort lauderdale, fla., nov. 03, 2020 (globe newswire) -- motus gi holdings, inc. , (nasdaq: mots) ("motus gi" or the "company"), a medical technology company providing endoscopy solutions to help improve clinical outcomes, is launching a new clinical protocol with nyu langone health to incorporate the company's pure-vu® gen2 system (pure-vu) with the intention to improve the management of its inpatient colonoscopies.
MOTS Ratings Summary
MOTS Quant Ranking